POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1kcw	CERULOPLASMIN (Homo sapiens)	5 / 12	THR A1033 ILE A 942 PHE A 901 PHE A 897 LEU A 895	None	1.40A	16.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1l9x	GAMMA-GLUTAMYL HYDROLASE (Homo sapiens)	5 / 12	SER A 205 THR A 195 ILE A 204 LEU A 157 PHE A 113	None	1.36A	24.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1nd7	WW DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	SER A 580 TRP A 615 THR A 676 LEU A 592 PHE A 776	None	1.34A	21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	2osa	N-CHIMAERIN (Homo sapiens)	5 / 12	THR A 356 ILE A 352 LEU A 401 PHE A 347 LEU A 343	None	1.05A	21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3cxl	N-CHIMERIN (Homo sapiens)	5 / 12	THR A 356 ILE A 352 LEU A 401 PHE A 347 LEU A 343	None	1.12A	20.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3pbl	D(3) DOPAMINE RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	7 / 12	THR A 115 ILE A 118 PHE A 338 TRP A 342 PHE A 345 PHE A 346 TYR A 373	None None None None ETQ  A1200 (-4.4A) ETQ  A1200 ( 4.5A) ETQ  A1200 (-4.4A)	0.54A	30.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3pds	FUSION PROTEIN BETA-2 ADRENERGIC RECEPTOR/LYSOZYME (Homo sapiens; Escherichia virus T4)	8 / 12	TRP A 109 THR A 118 ILE A 121 PHE A 282 TRP A 286 PHE A 289 PHE A 290 TYR A 316	None None None None None ERC  A1201 (-4.5A) ERC  A1201 (-4.8A) None	0.69A	30.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3rze	HISTAMINE H1 RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	8 / 12	TRP A 103 SER A 111 THR A 112 ILE A 115 PHE A 424 TRP A 428 PHE A 432 TYR A 458	None 5EH  A1200 ( 3.7A) D7V  A1201 ( 4.0A) D7V  A1201 (-3.8A) None 5EH  A1200 ( 3.4A) 5EH  A1200 ( 4.3A) 5EH  A1200 ( 4.4A)	0.53A	28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3u3z	MICROCEPHALIN (Homo sapiens)	5 / 12	SER A 819 THR A 821 ILE A 820 PHE A 756 LEU A 833	None	1.19A	17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4bqa	PROTEIN C-ETS-2 (Homo sapiens)	5 / 12	LEU A 354 PHE A 442 PHE A 391 LEU A 446 TYR A 424	None	1.13A	16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4gbr	BETA-2 ADRENERGIC RECEPTOR (Homo sapiens)	8 / 12	TRP A 109 THR A 118 ILE A 121 PHE A 254 TRP A 258 PHE A 261 PHE A 262 TYR A 288	None CAU  A 500 ( 4.7A) None None None CAU  A 500 (-4.2A) CAU  A 500 (-4.6A) CAU  A 500 (-4.6A)	0.67A	29.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4ib4	CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	5 / 12	LEU A 132 PHE A 333 TRP A 337 PHE A 341 TYR A 370	None None None None ERM  A2001 ( 4.8A)	1.41A	62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4ib4	CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	7 / 12	TRP A 131 SER A 139 THR A 140 ILE A 143 PHE A 340 PHE A 341 TYR A 370	None ERM  A2001 (-3.6A) ERM  A2001 (-3.9A) None ERM  A2001 (-4.3A) None ERM  A2001 ( 4.8A)	0.73A	62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4ib4	CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	8 / 12	TRP A 131 SER A 139 THR A 140 TRP A 337 PHE A 340 PHE A 341 LEU A 362 TYR A 370	None ERM  A2001 (-3.6A) ERM  A2001 (-3.9A) None ERM  A2001 (-4.3A) None ERM  A2001 ( 4.1A) ERM  A2001 ( 4.8A)	0.76A	62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4ib4	CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	7 / 12	TRP A 131 THR A 140 ILE A 143 PHE A 333 PHE A 340 PHE A 341 TYR A 370	None ERM  A2001 (-3.9A) None None ERM  A2001 (-4.3A) None ERM  A2001 ( 4.8A)	0.90A	62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4ib4	CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	8 / 12	TRP A 131 THR A 140 PHE A 333 TRP A 337 PHE A 340 PHE A 341 LEU A 362 TYR A 370	None ERM  A2001 (-3.9A) None None ERM  A2001 (-4.3A) None ERM  A2001 ( 4.1A) ERM  A2001 ( 4.8A)	0.86A	62.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4lde	LYSOZYME, BETA-2 ADRENERGIC RECEPTOR (Homo sapiens; Escherichia virus T4)	6 / 12	TRP A1109 THR A1118 ILE A1121 PHE A1289 PHE A1290 TYR A1316	None None None P0G  A1401 ( 4.7A) P0G  A1401 ( 4.9A) None	0.87A	24.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4lde	LYSOZYME, BETA-2 ADRENERGIC RECEPTOR (Homo sapiens; Escherichia virus T4)	6 / 12	TRP A1109 THR A1118 TRP A1286 PHE A1289 PHE A1290 TYR A1316	None None None P0G  A1401 ( 4.7A) P0G  A1401 ( 4.9A) None	0.68A	24.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5i2x	ADRENOCORTICAL DYSPLASIA PROTEIN HOMOLOG (Homo sapiens)	5 / 12	SER A 165 THR A 164 TRP A 167 PHE A 173 LEU A 117	None	1.38A	16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5v54	5-HYDROXYTRYPTAMINE RECEPTOR 1B,OB-1 FUSED 5-HT1B RECEPTOR,5-HYDROXYTR YPTAMINE RECEPTOR 1B (Spodoptera frugiperda; Homo sapiens)	8 / 12	SER A 106 TRP A 125 THR A 134 ILE A 137 PHE A 323 TRP A 327 PHE A 330 PHE A 331	None None 89F  A1201 (-4.2A) None None 89F  A1201 (-3.6A) 89F  A1201 (-4.1A) 89F  A1201 (-4.6A)	0.87A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5v54	5-HYDROXYTRYPTAMINE RECEPTOR 1B,OB-1 FUSED 5-HT1B RECEPTOR,5-HYDROXYTR YPTAMINE RECEPTOR 1B (Spodoptera frugiperda; Homo sapiens)	8 / 12	SER A 106 TRP A 125 THR A 134 ILE A 137 TRP A 327 PHE A 330 PHE A 331 TYR A 359	None None 89F  A1201 (-4.2A) None 89F  A1201 (-3.6A) 89F  A1201 (-4.1A) 89F  A1201 (-4.6A) None	0.63A	undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5wiv	D(4) DOPAMINE RECEPTOR, SOLUBLE CYTOCHROME B562 CHIMERA (Escherichia coli; Homo sapiens)	7 / 12	THR A 120 ILE A 123 PHE A 403 TRP A 407 PHE A 410 PHE A 411 TYR A 438	AQD  A1201 (-4.4A) None None None AQD  A1201 (-4.7A) AQD  A1201 (-4.6A) None	0.78A	44.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6bqh	5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	11 / 12	SER A 110 TRP A 130 SER A 138 THR A 139 ILE A 142 PHE A 320 TRP A 324 PHE A 327 PHE A 328 LEU A 350 TYR A 358	E2J  A1201 ( 4.5A) None E2J  A1201 (-3.2A) E2J  A1201 (-4.3A) E2J  A1201 (-3.5A) E2J  A1201 (-4.4A) E2J  A1201 ( 3.7A) E2J  A1201 (-4.6A) E2J  A1201 (-4.4A) E2J  A1201 ( 4.3A) None	0.49A	undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6cm4	D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA (Homo sapiens; Escherichia virus T4)	6 / 12	THR A 119 PHE A 382 TRP A 386 PHE A 389 PHE A 390 TYR A 416	8NU  A2001 ( 4.4A) 8NU  A2001 ( 4.7A) 8NU  A2001 ( 3.8A) 8NU  A2001 ( 4.5A) 8NU  A2001 ( 4.8A) 8NU  A2001 ( 4.9A)	0.53A	33.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6eua	ANGIOPOIETIN-RELATED PROTEIN 3 (Homo sapiens)	5 / 12	LEU A 362 PHE A 306 TRP A 314 PHE A 381 LEU A 351	None	1.32A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6g79	5-HYDROXYTRYPTAMINE RECEPTOR 1B (Homo sapiens)	7 / 12	SER S 106 TRP S 125 THR S 134 TRP S 327 PHE S 330 PHE S 331 TYR S 359	None None EP5  S 401 (-3.8A) None EP5  S 401 (-4.0A) EP5  S 401 (-4.7A) EP5  S 401 ( 4.9A)	0.81A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_A_8NUA3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6g79	5-HYDROXYTRYPTAMINE RECEPTOR 1B (Homo sapiens)	5 / 12	THR S 134 PHE S 323 TRP S 327 PHE S 330 PHE S 331	EP5  S 401 (-3.8A) None None EP5  S 401 (-4.0A) EP5  S 401 (-4.7A)	1.34A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1ly7	FRATAXIN (Homo sapiens)	5 / 12	THR A 191 PHE A 110 PHE A 109 LEU A 132 VAL A 134	None	1.06A	16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1nd7	WW DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	SER A 580 TRP A 615 THR A 676 LEU A 592 PHE A 776	None	1.32A	21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1o1u	GASTROTROPIN (Homo sapiens)	5 / 12	SER A  69 VAL A  91 THR A 100 PHE A  47 PHE A   2	None	1.14A	13.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1pcg	ESTROGEN RECEPTOR (Homo sapiens)	6 / 12	TYR A 328 VAL A 392 SER A 432 THR A 431 LEU A 349 LEU A 408	None None None None EST  A   1 ( 4.8A) None	1.49A	21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1szb	MANNOSE BINDING LECTIN-ASSOCIATED SERINE PROTEASE-2 RELATED PROTEIN, MAP19 (19KDA) (Homo sapiens)	5 / 12	TYR A  92 THR A  82 LEU A  71 PHE A  49 LEU A  44	TYR  A  92 ( 1.3A) THR  A  82 ( 0.8A) LEU  A  71 ( 0.6A) PHE  A  49 ( 1.3A) LEU  A  44 ( 0.6A)	1.31A	19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1wl4	ACETYL-COENZYME A ACETYLTRANSFERASE 2 (Homo sapiens)	5 / 12	THR A 306 LEU A  96 TRP A 310 LEU A 366 VAL A 394	None	1.30A	23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	2a1r	POLY(A)-SPECIFIC RIBONUCLEASE PARN (Homo sapiens)	5 / 12	TYR A  54 VAL A 284 LEU A 290 PHE A  69 VAL A 297	None	1.26A	21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	2b49	PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 3 (Homo sapiens)	5 / 12	VAL A 840 THR A 849 LEU A 831 PHE A 824 PHE A 821	None	1.36A	19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	2ckh	SENTRIN-SPECIFIC PROTEASE 1 (Homo sapiens)	5 / 12	VAL A 509 LEU A 567 PHE A 493 LEU A 524 VAL A 526	None	1.30A	18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3cem	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	5 / 12	LEU A 581 PHE A 750 PHE A 749 LEU A 622 VAL A 626	None	1.31A	18.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3o57	CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B (Homo sapiens)	5 / 12	VAL A 371 THR A 367 LEU A 250 LEU A 384 VAL A 383	None	1.10A	21.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3pbl	D(3) DOPAMINE RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	5 / 12	VAL A 111 THR A 115 TRP A 342 PHE A 345 PHE A 346	ETQ  A1200 (-3.4A) None None ETQ  A1200 (-4.4A) ETQ  A1200 ( 4.5A)	0.44A	30.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3pds	FUSION PROTEIN BETA-2 ADRENERGIC RECEPTOR/LYSOZYME (Homo sapiens; Escherichia virus T4)	6 / 12	TRP A 109 VAL A 114 THR A 118 TRP A 286 PHE A 289 PHE A 290	None ERC  A1201 (-3.8A) None None ERC  A1201 (-4.5A) ERC  A1201 (-4.8A)	0.51A	30.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3rze	HISTAMINE H1 RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	5 / 12	TRP A 103 SER A 111 THR A 112 TRP A 428 PHE A 432	None 5EH  A1200 ( 3.7A) D7V  A1201 ( 4.0A) 5EH  A1200 ( 3.4A) 5EH  A1200 ( 4.3A)	0.58A	28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3zrh	UBIQUITIN THIOESTERASE ZRANB1 (Homo sapiens)	5 / 12	VAL A 528 THR A 524 LEU A 375 LEU A 449 VAL A 448	None	1.29A	22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4asc	KELCH REPEAT AND BTB DOMAIN-CONTAINING PROTEIN 5 (Homo sapiens)	5 / 12	VAL A 363 SER A 353 PHE A 321 LEU A 613 VAL A 611	None	1.14A	23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4bkf	EPHRIN-B3 (Homo sapiens)	5 / 12	TYR C  51 LEU C  30 TRP C  35 LEU C 165 VAL C 163	None	1.18A	17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4fww	MACROPHAGE-STIMULATI NG PROTEIN RECEPTOR (Homo sapiens)	5 / 12	VAL A 461 THR A 454 LEU A 483 LEU A 443 VAL A 366	None	1.27A	21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4gbr	BETA-2 ADRENERGIC RECEPTOR (Homo sapiens)	6 / 12	TRP A 109 VAL A 114 THR A 118 TRP A 258 PHE A 261 PHE A 262	None CAU  A 500 (-3.5A) CAU  A 500 ( 4.7A) None CAU  A 500 (-4.2A) CAU  A 500 (-4.6A)	0.51A	29.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4ib4	CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	7 / 12	TRP A 131 VAL A 136 SER A 139 THR A 140 PHE A 340 PHE A 341 VAL A 366	None ERM  A2001 (-3.8A) ERM  A2001 (-3.6A) ERM  A2001 (-3.9A) ERM  A2001 (-4.3A) None ERM  A2001 ( 4.2A)	0.73A	62.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4ib4	CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	8 / 12	TRP A 131 VAL A 136 SER A 139 TRP A 337 PHE A 340 PHE A 341 LEU A 362 VAL A 366	None ERM  A2001 (-3.8A) ERM  A2001 (-3.6A) None ERM  A2001 (-4.3A) None ERM  A2001 ( 4.1A) ERM  A2001 ( 4.2A)	0.82A	62.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4lde	LYSOZYME, BETA-2 ADRENERGIC RECEPTOR (Homo sapiens; Escherichia virus T4)	6 / 12	TRP A1109 VAL A1114 THR A1118 TRP A1286 PHE A1289 PHE A1290	None P0G  A1401 (-3.7A) None None P0G  A1401 ( 4.7A) P0G  A1401 ( 4.9A)	0.70A	24.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4qt8	MACROPHAGE-STIMULATI NG PROTEIN RECEPTOR (Homo sapiens)	5 / 12	VAL B 461 THR B 454 LEU B 483 LEU B 443 VAL B 366	None	1.31A	20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5i2x	ADRENOCORTICAL DYSPLASIA PROTEIN HOMOLOG (Homo sapiens)	5 / 12	SER A 165 THR A 164 TRP A 167 PHE A 173 LEU A 117	None	1.37A	16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5neu	INTEGRIN ALPHA-V (Homo sapiens)	5 / 12	SER A 225 SER A 316 THR A 329 PHE A 267 VAL A 253	None	0.99A	21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5v54	5-HYDROXYTRYPTAMINE RECEPTOR 1B,OB-1 FUSED 5-HT1B RECEPTOR,5-HYDROXYTR YPTAMINE RECEPTOR 1B (Spodoptera frugiperda; Homo sapiens)	6 / 12	SER A 106 TRP A 125 THR A 134 TRP A 327 PHE A 330 PHE A 331	None None 89F  A1201 (-4.2A) 89F  A1201 (-3.6A) 89F  A1201 (-4.1A) 89F  A1201 (-4.6A)	0.53A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5w0m	TERMINAL URIDYLYLTRANSFERASE 7 (Homo sapiens)	5 / 12	SER A1233 VAL A1004 LEU A1239 PHE A 997 LEU A 993	None	1.35A	22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5w0m	TERMINAL URIDYLYLTRANSFERASE 7 (Homo sapiens)	5 / 12	SER A1233 VAL A1004 LEU A1239 PHE A1318 LEU A 993	None	1.29A	22.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5wiv	D(4) DOPAMINE RECEPTOR, SOLUBLE CYTOCHROME B562 CHIMERA (Escherichia coli; Homo sapiens)	5 / 12	VAL A 116 THR A 120 TRP A 407 PHE A 410 PHE A 411	AQD  A1201 ( 3.9A) AQD  A1201 (-4.4A) None AQD  A1201 (-4.7A) AQD  A1201 (-4.6A)	0.72A	44.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6bqh	5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	10 / 12	SER A 110 TRP A 130 VAL A 135 SER A 138 THR A 139 TRP A 324 PHE A 327 PHE A 328 LEU A 350 VAL A 354	E2J  A1201 ( 4.5A) None E2J  A1201 (-3.8A) E2J  A1201 (-3.2A) E2J  A1201 (-4.3A) E2J  A1201 ( 3.7A) E2J  A1201 (-4.6A) E2J  A1201 (-4.4A) E2J  A1201 ( 4.3A) E2J  A1201 (-4.6A)	0.58A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6bqh	5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	10 / 12	SER A 110 TYR A 118 TRP A 130 VAL A 135 THR A 139 TRP A 324 PHE A 327 PHE A 328 LEU A 350 VAL A 354	E2J  A1201 ( 4.5A) None None E2J  A1201 (-3.8A) E2J  A1201 (-4.3A) E2J  A1201 ( 3.7A) E2J  A1201 (-4.6A) E2J  A1201 (-4.4A) E2J  A1201 ( 4.3A) E2J  A1201 (-4.6A)	0.68A	undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6cm4	D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA (Homo sapiens; Escherichia virus T4)	5 / 12	VAL A 115 THR A 119 TRP A 386 PHE A 389 PHE A 390	8NU  A2001 ( 3.5A) 8NU  A2001 ( 4.4A) 8NU  A2001 ( 3.8A) 8NU  A2001 ( 4.5A) 8NU  A2001 ( 4.8A)	0.45A	33.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6g79	5-HYDROXYTRYPTAMINE RECEPTOR 1B (Homo sapiens)	5 / 12	SER S 106 TRP S 125 THR S 134 PHE S 330 PHE S 331	None None EP5  S 401 (-3.8A) EP5  S 401 (-4.0A) EP5  S 401 (-4.7A)	0.79A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_0 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6g79	5-HYDROXYTRYPTAMINE RECEPTOR 1B (Homo sapiens)	5 / 12	SER S 106 TRP S 125 TRP S 327 PHE S 330 PHE S 331	None None None EP5  S 401 (-4.0A) EP5  S 401 (-4.7A)	0.72A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	1yck	PEPTIDOGLYCAN RECOGNITION PROTEIN (Homo sapiens)	4 / 5	ASP A  81 ILE A 124 ASN A  58 TYR A  85	None	0.98A	18.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3pbl	D(3) DOPAMINE RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	4 / 5	ASP A 110 ILE A 118 PHE A 338 TYR A 373	ETQ  A1200 (-3.5A) None None ETQ  A1200 (-4.4A)	0.46A	30.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3pds	FUSION PROTEIN BETA-2 ADRENERGIC RECEPTOR/LYSOZYME (Homo sapiens; Escherichia virus T4)	4 / 5	ASP A 113 ILE A 121 PHE A 282 TYR A 316	ERC  A1201 (-3.7A) None None None	0.64A	30.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3rze	HISTAMINE H1 RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	4 / 5	ASP A 107 ILE A 115 PHE A 424 TYR A 458	5EH  A1200 ( 2.6A) D7V  A1201 (-3.8A) None 5EH  A1200 ( 4.4A)	0.48A	28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3she	MAP KINASE-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	4 / 5	ASP A 149 ILE A 130 PHE A 138 ASN A 305	None	1.21A	21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3u2p	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4 (Homo sapiens)	4 / 5	ILE A 379 PHE A 389 ASN A 470 TYR A 444	None None NAG  A1005 (-1.8A) None	1.10A	21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	3u7u	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4 (Homo sapiens)	4 / 5	ILE A 379 PHE A 389 ASN A 470 TYR A 444	None	1.25A	19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4gbr	BETA-2 ADRENERGIC RECEPTOR (Homo sapiens)	4 / 5	ASP A 113 ILE A 121 PHE A 254 TYR A 288	CAU  A 500 (-3.0A) None None CAU  A 500 (-4.6A)	0.59A	29.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4h1s	5'-NUCLEOTIDASE (Homo sapiens)	4 / 5	ASP A 226 ILE A  31 ASN A 117 TYR A 176	None None ZN  A 602 ( 2.7A) None	1.19A	21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4owt	INTEGRATOR COMPLEX SUBUNIT 3 (Homo sapiens)	4 / 5	ASP A 117 ILE A 126 PHE A  94 ASN A  76	None	1.20A	22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4rwa	SOLUBLE CYTOCHROME B562,DELTA-TYPE OPIOID RECEPTOR (Escherichia coli; Homo sapiens)	4 / 5	ASP A 128 ILE A 136 PHE A 270 TYR A 308	None	0.58A	21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	4zdv	MICROTUBULE-ASSOCIAT ED PROTEINS 1A/1B LIGHT CHAIN 3A (Homo sapiens)	4 / 5	ASP A 106 ILE A  23 ASN A  84 TYR A 110	None	0.93A	16.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5clw	1,4-ALPHA-GLUCAN-BRA NCHING ENZYME (Homo sapiens)	4 / 5	ASP A 286 ILE A 206 PHE A 551 TYR A 251	None	1.08A	20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5dst	PROTEIN ARGININE N-METHYLTRANSFERASE 8 (Homo sapiens)	4 / 5	ASP A  92 ILE A 124 PHE A 128 ASN A 312	None	1.18A	21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5lsk	PROTEIN MIS12 HOMOLOG POLYAMINE-MODULATED FACTOR 1 (Homo sapiens; Homo sapiens)	4 / 5	ASP B  39 ILE B  88 PHE A  28 ASN B 100	None	1.24A	16.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5wiv	D(4) DOPAMINE RECEPTOR, SOLUBLE CYTOCHROME B562 CHIMERA (Escherichia coli; Homo sapiens)	4 / 5	ASP A 115 ILE A 123 PHE A 403 TYR A 438	AQD  A1201 (-3.3A) None None None	0.41A	44.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	5x49	PROBABLE XAA-PRO AMINOPEPTIDASE 3 (Homo sapiens)	4 / 5	ILE A 343 PHE A 266 ASN A 319 TYR A 283	None	1.15A	20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6bqh	5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	5 / 5	ASP A 134 ILE A 142 PHE A 320 ASN A 351 TYR A 358	E2J  A1201 (-3.0A) E2J  A1201 (-3.5A) E2J  A1201 (-4.4A) E2J  A1201 (-3.8A) None	0.47A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A93_B_8NUB3001_1 (5-HYDROXYTRYPTAMINE RECEPTOR 2A,SOLUBLE CYTOCHROME B562)	6c0t	CGMP-DEPENDENT PROTEIN KINASE 1 (Homo sapiens)	4 / 5	ASP A 597 ILE A 591 PHE A 579 ASN A 568	None	1.03A	undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3pbl	D(3) DOPAMINE RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	8 / 12	PHE A 106 VAL A 111 THR A 115 PHE A 338 TRP A 342 PHE A 346 THR A 369 TYR A 373	ETQ  A1200 (-4.8A) ETQ  A1200 (-3.4A) None None None ETQ  A1200 ( 4.5A) ETQ  A1200 (-4.5A) ETQ  A1200 (-4.4A)	0.69A	74.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3pbl	D(3) DOPAMINE RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	5 / 12	VAL A 111 CYH A 114 THR A 115 TRP A 342 THR A 369	ETQ  A1200 (-3.4A) ETQ  A1200 (-4.0A) None None ETQ  A1200 (-4.5A)	1.16A	74.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3pbl	D(3) DOPAMINE RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	5 / 12	VAL A 111 CYH A 114 THR A 115 TRP A 342 TYR A 365	ETQ  A1200 (-3.4A) ETQ  A1200 (-4.0A) None None None	1.34A	74.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3pbl	D(3) DOPAMINE RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	5 / 12	VAL A 111 SER A 192 PHE A 338 TRP A 342 PHE A 346	ETQ  A1200 (-3.4A) ETQ  A1200 (-3.3A) None None ETQ  A1200 ( 4.5A)	0.98A	74.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3pbl	D(3) DOPAMINE RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	6 / 12	VAL A 111 THR A 115 PHE A 338 TRP A 342 PHE A 346 TYR A 365	ETQ  A1200 (-3.4A) None None None ETQ  A1200 ( 4.5A) None	0.90A	74.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3pds	FUSION PROTEIN BETA-2 ADRENERGIC RECEPTOR/LYSOZYME (Homo sapiens; Escherichia virus T4)	5 / 12	PHE A 282 TRP A 286 PHE A 290 TYR A 308 TYR A 316	None None ERC  A1201 (-4.8A) None None	0.84A	57.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3pds	FUSION PROTEIN BETA-2 ADRENERGIC RECEPTOR/LYSOZYME (Homo sapiens; Escherichia virus T4)	5 / 12	SER A 203 PHE A 282 TRP A 286 PHE A 290 TYR A 308	ERC  A1201 (-2.8A) None None ERC  A1201 (-4.8A) None	1.06A	57.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3pds	FUSION PROTEIN BETA-2 ADRENERGIC RECEPTOR/LYSOZYME (Homo sapiens; Escherichia virus T4)	6 / 12	VAL A 114 THR A 118 PHE A 282 TRP A 286 PHE A 290 TYR A 316	ERC  A1201 (-3.8A) None None None ERC  A1201 (-4.8A) None	0.73A	57.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3pds	FUSION PROTEIN BETA-2 ADRENERGIC RECEPTOR/LYSOZYME (Homo sapiens; Escherichia virus T4)	6 / 12	VAL A 114 THR A 118 SER A 203 PHE A 282 TRP A 286 PHE A 290	ERC  A1201 (-3.8A) None ERC  A1201 (-2.8A) None None ERC  A1201 (-4.8A)	0.92A	57.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	3rze	HISTAMINE H1 RECEPTOR, LYSOZYME CHIMERA (Homo sapiens; Escherichia virus T4)	5 / 12	THR A 112 PHE A 424 TRP A 428 PHE A 432 TYR A 458	D7V  A1201 ( 4.0A) None 5EH  A1200 ( 3.4A) 5EH  A1200 ( 4.3A) 5EH  A1200 ( 4.4A)	0.55A	58.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	4gbr	BETA-2 ADRENERGIC RECEPTOR (Homo sapiens)	5 / 12	PHE A 254 TRP A 258 PHE A 262 TYR A 280 TYR A 288	None None CAU  A 500 (-4.6A) None CAU  A 500 (-4.6A)	0.64A	25.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	4gbr	BETA-2 ADRENERGIC RECEPTOR (Homo sapiens)	6 / 12	VAL A 114 THR A 118 PHE A 254 TRP A 258 PHE A 262 TYR A 288	CAU  A 500 (-3.5A) CAU  A 500 ( 4.7A) None None CAU  A 500 (-4.6A) CAU  A 500 (-4.6A)	0.74A	25.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	4ib4	CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	6 / 12	VAL A 136 THR A 140 PHE A 333 TRP A 337 PHE A 341 TYR A 370	ERM  A2001 (-3.8A) ERM  A2001 (-3.9A) None None None ERM  A2001 ( 4.8A)	1.03A	30.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	4lde	LYSOZYME, BETA-2 ADRENERGIC RECEPTOR (Homo sapiens; Escherichia virus T4)	5 / 12	VAL A1114 THR A1118 SER A1203 TRP A1286 PHE A1290	P0G  A1401 (-3.7A) None P0G  A1401 (-2.9A) None P0G  A1401 ( 4.9A)	1.02A	32.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	4lde	LYSOZYME, BETA-2 ADRENERGIC RECEPTOR (Homo sapiens; Escherichia virus T4)	5 / 12	VAL A1114 THR A1118 TRP A1286 PHE A1290 TYR A1316	P0G  A1401 (-3.7A) None None P0G  A1401 ( 4.9A) None	0.65A	32.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	4m7f	FIBRINOGEN C DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	TRP A 410 PHE A 350 VAL A 333 SER A 450 TYR A 302	None	1.37A	17.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	4r9j	FICOLIN-2 (Homo sapiens)	5 / 12	TRP G 241 PHE G 185 VAL G 168 SER G 281 TYR G 137	None	1.42A	19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5a31	ANAPHASE-PROMOTING COMPLEX SUBUNIT 1 ANAPHASE-PROMOTING COMPLEX SUBUNIT 2 (Homo sapiens; Homo sapiens)	5 / 12	VAL A1848 CYH A1850 THR A1851 PHE N 163 THR N 155	None	1.41A	14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5v54	5-HYDROXYTRYPTAMINE RECEPTOR 1B,OB-1 FUSED 5-HT1B RECEPTOR,5-HYDROXYTR YPTAMINE RECEPTOR 1B (Spodoptera frugiperda; Homo sapiens)	6 / 12	CYH A 133 THR A 134 TRP A 327 PHE A 331 THR A 355 TYR A 359	89F  A1201 (-4.5A) 89F  A1201 (-4.2A) 89F  A1201 (-3.6A) 89F  A1201 (-4.6A) 89F  A1201 (-4.0A) None	0.42A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5v54	5-HYDROXYTRYPTAMINE RECEPTOR 1B,OB-1 FUSED 5-HT1B RECEPTOR,5-HYDROXYTR YPTAMINE RECEPTOR 1B (Spodoptera frugiperda; Homo sapiens)	5 / 12	THR A 134 PHE A 323 TRP A 327 PHE A 331 THR A 355	89F  A1201 (-4.2A) None 89F  A1201 (-3.6A) 89F  A1201 (-4.6A) 89F  A1201 (-4.0A)	0.79A	undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5wiv	D(4) DOPAMINE RECEPTOR, SOLUBLE CYTOCHROME B562 CHIMERA (Escherichia coli; Homo sapiens)	5 / 12	CYH A 119 THR A 120 SER A 197 TRP A 407 THR A 434	AQD  A1201 ( 3.9A) AQD  A1201 (-4.4A) AQD  A1201 ( 4.0A) None AQD  A1201 (-3.5A)	1.31A	35.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5wiv	D(4) DOPAMINE RECEPTOR, SOLUBLE CYTOCHROME B562 CHIMERA (Escherichia coli; Homo sapiens)	5 / 12	THR A 120 SER A 197 PHE A 403 TRP A 407 THR A 434	AQD  A1201 (-4.4A) AQD  A1201 ( 4.0A) None None AQD  A1201 (-3.5A)	1.00A	35.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5wiv	D(4) DOPAMINE RECEPTOR, SOLUBLE CYTOCHROME B562 CHIMERA (Escherichia coli; Homo sapiens)	5 / 12	VAL A 116 CYH A 119 THR A 120 TRP A 407 THR A 434	AQD  A1201 ( 3.9A) AQD  A1201 ( 3.9A) AQD  A1201 (-4.4A) None AQD  A1201 (-3.5A)	1.14A	35.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5wiv	D(4) DOPAMINE RECEPTOR, SOLUBLE CYTOCHROME B562 CHIMERA (Escherichia coli; Homo sapiens)	6 / 12	VAL A 116 PHE A 403 TRP A 407 PHE A 411 THR A 434 TYR A 438	AQD  A1201 ( 3.9A) None None AQD  A1201 (-4.6A) AQD  A1201 (-3.5A) None	0.68A	35.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5wiv	D(4) DOPAMINE RECEPTOR, SOLUBLE CYTOCHROME B562 CHIMERA (Escherichia coli; Homo sapiens)	5 / 12	VAL A 116 SER A 196 PHE A 403 TRP A 407 PHE A 411	AQD  A1201 ( 3.9A) AQD  A1201 (-2.8A) None None AQD  A1201 (-4.6A)	1.12A	35.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5wiv	D(4) DOPAMINE RECEPTOR, SOLUBLE CYTOCHROME B562 CHIMERA (Escherichia coli; Homo sapiens)	6 / 12	VAL A 116 THR A 120 PHE A 403 TRP A 407 THR A 434 TYR A 438	AQD  A1201 ( 3.9A) AQD  A1201 (-4.4A) None None AQD  A1201 (-3.5A) None	0.40A	35.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	6bqh	5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	5 / 12	THR A 139 SER A 219 PHE A 320 TRP A 324 PHE A 328	E2J  A1201 (-4.3A) E2J  A1201 (-3.2A) E2J  A1201 (-4.4A) E2J  A1201 ( 3.7A) E2J  A1201 (-4.4A)	0.95A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	6bqh	5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	6 / 12	VAL A 135 THR A 139 PHE A 320 TRP A 324 PHE A 328 TYR A 358	E2J  A1201 (-3.8A) E2J  A1201 (-4.3A) E2J  A1201 (-4.4A) E2J  A1201 ( 3.7A) E2J  A1201 (-4.4A) None	0.40A	undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	6cm4	D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA (Homo sapiens; Escherichia virus T4)	5 / 12	SER A 194 PHE A 382 TRP A 386 TYR A 408 THR A 412	None 8NU  A2001 ( 4.7A) 8NU  A2001 ( 3.8A) 8NU  A2001 ( 4.0A) 8NU  A2001 ( 3.8A)	0.79A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	6cm4	D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA (Homo sapiens; Escherichia virus T4)	12 / 12	TRP A 100 PHE A 110 VAL A 115 CYH A 118 THR A 119 SER A 193 PHE A 382 TRP A 386 PHE A 390 TYR A 408 THR A 412 TYR A 416	None 8NU  A2001 ( 4.9A) 8NU  A2001 ( 3.5A) 8NU  A2001 ( 4.0A) 8NU  A2001 ( 4.4A) 8NU  A2001 ( 4.5A) 8NU  A2001 ( 4.7A) 8NU  A2001 ( 3.8A) 8NU  A2001 ( 4.8A) 8NU  A2001 ( 4.0A) 8NU  A2001 ( 3.8A) 8NU  A2001 ( 4.9A)	0.00A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	6g79	5-HYDROXYTRYPTAMINE RECEPTOR 1B (Homo sapiens)	5 / 12	CYH S 133 THR S 134 PHE S 331 TYR S 109 TYR S 359	EP5  S 401 (-4.2A) EP5  S 401 (-3.8A) EP5  S 401 (-4.7A) None EP5  S 401 ( 4.9A)	1.34A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	6g79	5-HYDROXYTRYPTAMINE RECEPTOR 1B (Homo sapiens)	5 / 12	CYH S 133 THR S 134 TRP S 327 THR S 355 TYR S 359	EP5  S 401 (-4.2A) EP5  S 401 (-3.8A) None None EP5  S 401 ( 4.9A)	0.82A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_0 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	6g79	5-HYDROXYTRYPTAMINE RECEPTOR 1B (Homo sapiens)	5 / 12	CYH S 133 TRP S 327 PHE S 331 THR S 355 TYR S 359	EP5  S 401 (-4.2A) None EP5  S 401 (-4.7A) None EP5  S 401 ( 4.9A)	0.90A	undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_1 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	4zgz	ANTIZYME INHIBITOR 1 ORNITHINE DECARBOXYLASE ANTIZYME 1 (Homo sapiens; Homo sapiens)	4 / 4	ASP A 387 ALA A  88 SER A  90 PHE B 192	None	1.41A	22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_1 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5c5b	DCC-INTERACTING PROTEIN 13-ALPHA (Homo sapiens)	4 / 4	ASP A  15 ALA A 142 SER A 170 PHE A 133	None	1.46A	21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_1 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	5xjy	ATP-BINDING CASSETTE SUB-FAMILY A MEMBER 1 (Homo sapiens)	4 / 4	ASP A1706 ALA A1766 SER A1757 PHE A1675	None	1.40A	11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CM4_A_8NUA2001_1 (D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA)	6cm4	D(2) DOPAMINE RECEPTOR, ENDOLYSIN CHIMERA (Homo sapiens; Escherichia virus T4)	4 / 4	ASP A 114 ALA A 122 SER A 197 PHE A 389	8NU  A2001 ( 3.0A) 8NU  A2001 ( 3.3A) 8NU  A2001 ( 3.6A) 8NU  A2001 ( 4.5A)	0.01A	undetectable